John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$226M |
| 2 |
JPMorgan Chase
JPM
|
+$212M |
| 3 |
TSMC
TSM
|
+$204M |
| 4 |
Occidental Petroleum
OXY
|
+$194M |
| 5 |
Apple
AAPL
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$271M |
| 2 |
Microsoft
MSFT
|
+$267M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$255M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$226M |
| 5 |
Coca-Cola
KO
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.48% |
| 2 | Healthcare | 15.21% |
| 3 | Industrials | 10.23% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Financials | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
B&G Foods
BGS
$284M
| $5.98M | 0.02% |
221,793
+98,985
| +81% | +$2.98M |
|
827
AutoNation
AN
$6.45B
| $5.97M | 0.02% |
59,974
-317,744
| -84% | -$35.1M |
|
|
TVTY
828
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $5.95M | 0.02% |
+184,800
| New | +$5M |
|
829
Watsco Inc
WSO
$12.8B
| $5.92M | 0.02% |
19,423
+14,900
| +329% | +$4.25M |
|
|
ENDP
830
DELISTED
Endo International plc
ENDP
| $5.91M | 0.02% |
2,559,607
-1,745,008
| -41% | -$5.12M |
|
831
McDonald's
MCD
$193B
| $5.91M | 0.02% |
23,902
-624,429
| -96% | -$156M |
|
832
GXO Logistics
GXO
$5.39B
| $5.9M | 0.02% |
82,656
+77,456
| +1,490% | +$6.19M |
|
833
PUT
Clarivate
CLVT
$1.36B
| $5.89M | 0.02% |
351,700
+25,000
| +8% | +$414K |
|
|
CMPS
834
Compass Pathways
CMPS
$1.97B
| $5.87M | 0.02% |
455,489
+79,389
| +21% | +$1.18M |
|
|
WW
835
DELISTED
WW International
WW
| $5.86M | 0.02% |
+572,290
| New | +$6.72M |
|
836
lululemon athletica
LULU
$13.9B
| $5.85M | 0.02% |
+16,009
| New | +$5.21M |
|
|
TWOU
837
DELISTED
2U Inc
TWOU
| $5.84M | 0.02% |
14,657
+10,881
| +288% | +$4.38M |
|
|
AVTA
838
DELISTED
Avantax, Inc. Common Stock
AVTA
| $5.83M | 0.02% |
298,113
+254,103
| +577% | +$4.61M |
|
839
Acadia Pharmaceuticals
ACAD
$5.11B
| $5.82M | 0.02% |
240,471
+214,371
| +821% | +$5.19M |
|
|
SLCA
840
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $5.79M | 0.02% |
+310,371
| New | +$3.92M |
|
841
Sixth Street Specialty
TSLX
$1.8B
| $5.79M | 0.02% |
248,406
-76,348
| -24% | -$1.79M |
|
842
Brinker International
EAT
$10.9B
| $5.76M | 0.02% |
151,053
-108,291
| -42% | -$4.05M |
|
843
EPR Properties
EPR
$4.64B
| $5.76M | 0.02% |
105,341
+58,002
| +123% | +$2.81M |
|
|
HMA
844
DELISTED
Heartland Media Acquisition Corp.
HMA
| $5.76M | 0.02% |
+583,332
| New | +$5.77M |
|
845
Avnet
AVT
$7.08B
| $5.76M | 0.02% |
141,879
-230,537
| -62% | -$9.5M |
|
846
MDU Resources
MDU
$4.2B
| $5.76M | 0.02% |
+568,034
| New | +$6.01M |
|
847
Bruker
BRKR
$8.68B
| $5.75M | 0.02% |
89,476
-106,027
| -54% | -$7.25M |
|
848
KB Home
KBH
$3.41B
| $5.75M | 0.02% |
177,521
-441,646
| -71% | -$17.4M |
|
849
American Well
AMWL
$203M
| $5.74M | 0.02% |
68,200
-21,845
| -24% | -$1.84M |
|
850
Frontline
FRO
$9.81B
| $5.69M | 0.02% |
+646,258
| New | +$5.12M |
|
Similar funds
John Overdeck's Q1 2022 Portfolio in Review
As of Q1 2022, John Overdeck held 4,846 positions worth $33.9B, down 28% from $46.8B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
John Overdeck withdrew a net $11.3B in Q1 2022, closing 2,304 positions and reducing 976 holdings. Its most notable exit was Pfizer, an estimated $271M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, John Overdeck opened a new position in Cisco worth $223M.
- John Overdeck's largest Q1 2022 buy was Cisco: 4,001,362 shares worth $223M.
- John Overdeck added most to JPMorgan Chase in Q1 2022, an estimated $212M increase.
- John Overdeck's biggest Q1 2022 reduction was Coca-Cola, cutting an estimated $225M.
- John Overdeck fully exited Pfizer in Q1 2022, selling an estimated $271M.
- John Overdeck's ten largest holdings make up 7.2% of its $33.9B portfolio in Q1 2022.
- John Overdeck opened 656 new positions and closed 2,304 in Q1 2022.
- John Overdeck's portfolio value fell 28% quarter-over-quarter to $33.9B.
Based on Two Sigma Investments's 13F filing for Q1 2022, filed 16 May 2022.